The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $71.4 billion in 2017 alone.
PhRMA was formed in 1958 to represent America’s biopharmaceutical research companies and help promote smart public policy that supports medical research to address patient needs. Headquartered in Washington, D.C., with offices in leading biopharmaceutical research communities, PhRMA advocates in the United States and around the world for policies that support the discovery and development of innovative medicines. Our policy priorities include: explaining the increased complexity and risk of the research and development process; reinforcing the need for investment in R&D; ensuring broad access to and appropriate use of medicines; and emphasizing the importance of strong intellectual property incentives for new medicines.
Our 12 offices are located across the United States and in Tokyo, Japan, and Dubai, United Arab Emirates.
Washington, D.C. [Headquarters]
Baton Rouge, LA
St. Paul, MN
Dubai, United Arab Emirates